Brazil has authorized human trials of Vivaxin, an experimental malaria vaccine targeting Plasmodium vivax. The first study will assess safety and immune response in 48 volunteers—not yet vaccine effectiveness. #Brazil #Malaria
www.gov.br/saude/pt-br/...
